La vendita allo scoperto per Willis Towers Watson dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Willis Towers Watson. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Willis Towers Watson (NASDAQ:WTW) Azioni, Report sulle vendite allo scoperto

Willis Towers Watson

NYSE

In January 2016, Towers Watson and Willis Group merged to form Willis Towers Watson, a global advisory, insurance brokerage, and solutions company. The company operates in two business segments: health, wealth, and career (its consulting operations) and risk and brokering (its brokerage operations). It has about 48,000 employees.

Willis Towers Watson Public Limited Company - Ordinary Shares

Willis Towers Watson PLC

Westwing Group SE

The $1 billion increase is in addition to the approximately $660 million remaining on the current open-ended repurchase authority.

News

Buybacks

WTW Board Approves Increase To Existing Share Repurchase Authority In The Amount Of $1B

Barclays analyst Alex Scott maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Underweight and raises the price target from $278 to $302.

Price Target

Analyst Ratings

Barclays Maintains Underweight on Willis Towers Watson, Raises Price Target to $302

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Outperform and raises the price target from $352 to $359.

Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $359

Wells Fargo analyst Elyse Greenspan maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Overweight and raises the price target from $334 to $340.

Wells Fargo Maintains Overweight on Willis Towers Watson, Raises Price Target to $340

WIIM

Willis Towers Watson shares are trading higher after the company reported better-than-expected Q3 financial results.

Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) affirms FY2024 Adj EPS guidance from $16.00-17.00 to $16.00-17.00 vs $16.50 analyst estimate..

Guidance

Willis Towers Watson Affirms FY2024 Adj EPS Guidance from $16.00-17.00 to $16.00-17.00 vs $16.50 Est ;Revenue of $9.9B vs Est. 9.92B

Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) reported quarterly earnings of $2.93 per share which beat the analyst consensus estimate of $2.73 by 7.33 percent. The company reported quarterly sales of $2.289 billion which beat the analyst consensus estimate of $2.287 billion by 0.09 percent. This is a 5.68 percent increase over sales of $2.166 billion the same period last year.

Earnings

Earnings Beats

Willis Towers Watson Q3 2024 Adj. EPS $2.93 Beats $2.73 Estimate, Sales $2.289B Beat $2.287B Estimate

WTW Expands Japan Operations With New Corporate Insurance Brokerage

In the current market session, Willis Towers Watson Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) stock price is at $290.51, after a 0.42% drop. However, over the past month, the company's stock spiked by 0.08%, and in the past year, by 26.86%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1729696525_0.png" alt="Past Year Chart" />

<h3>Willis Towers Watson P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Willis Towers Watson has a lower P/E than the aggregate P/E of 56.04 of the Insurance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729696525_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: Willis Towers Watson

Jefferies analyst Yaron Kinar maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Hold and raises the price target from $295 to $314.

Jefferies Maintains Hold on Willis Towers Watson, Raises Price Target to $314

Wells Fargo analyst Elyse Greenspan maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Overweight and raises the price target from $321 to $334.

Wells Fargo Maintains Overweight on Willis Towers Watson, Raises Price Target to $334

The investment follows a successful alliance with atomos since the end of 2022, during which WTW&#39;s investment engine has successfully powered atomos&#39; multi-asset investment solutions.
This next step in the partnership sees WTW acquire part ownership in the business, as well as providing additional capital designed to support further growth.
&nbsp;

WTW Acquires A Stake In Atomos, The UK-based Advice-led Wealth Manager Backed By Funds Managed By Oaktree; Terms Not Disclosed

Roth MKM analyst Harry Fong maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Buy and raises the price target from $315 to $345.

Roth MKM Maintains Buy on Willis Towers Watson, Raises Price Target to $345

Truist Securities analyst Mark Hughes maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Buy and raises the price target from $335 to $365.

Truist Securities Maintains Buy on Willis Towers Watson, Raises Price Target to $365

<ul>
<li>Divestiture sharpens strategic focus, simplifies portfolio and expects to accelerate free cash flow margin expansion
<ul>
<li>Transaction expected to be completed by the end of 2024</li>
</ul>
</li>
</ul>

Asset Sales

WTW To Sell TRANZACT For $632.4M

Willis Towers Watson's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NYSE">WTW</a>) short percent of float has risen 5.66% since its last report. The company recently reported that it has 888 thousand shares sold short, which is 1.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Willis Towers Watson Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725993015_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Willis Towers Watson has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Willis Towers Watson's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Willis Towers Watson's peer group average for short interest as a percentage of float is 4.12%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Willis Towers Watson's Recent Short Interest

WTW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>), a leading global advisory, broking and solutions company today announced a partnership between its Affinity Insurance business and Kayna, the award-winning insurance infrastructure platform. The partnership has been developed to enable delivery of innovative WTW insurance solutions to SME clients in the UK and US through Vertical Software-as-a-Service (‘vSaaS') platforms. &nbsp;
Vertical SaaS platforms provide types of software solutions which are created for specific industries and the partnership between WTW and Kayna intends to provide full program administration for US and UK-based industry-specific platforms in the construction, legal, salon/spa, fitness and field service sectors, distributing tailored insurance solutions.
Specialist WTW teams in the UK and US will lead the product development and broker all insurance offerings as the company affirms its primary focus to delivering next generation distribution for the fast-growing Affinity Insurance sector.
The partnership between WTW Affinity and Kayna will enable WTW to distribute property, general liability, workers' compensation, commercial auto and umbrella liability insurance solutions to industry-specific vSaaS platforms. The partnership aims to drive top-line growth for vSaaS platform providers by leveraging platform data to serve relevant, tailored insurance through a streamlined process direct to the customer base that use such platforms to run their day-to-day business operations.

Government

Regulations

WTW Partners with Kayna to Deliver Tailored Insurance Solutions for SMEs in US and UK

Barclays analyst Alex Scott initiates coverage on Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Underweight rating and announces Price Target of $278.

Initiation

Barclays Initiates Coverage On Willis Towers Watson with Underweight Rating, Announces Price Target of $278

Brown &amp; Brown, Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) shares have jumped 40% year to date (YTD) compared with the industry&#39;s growth of 20.6%. The Finance sector and the Zacks S&amp;P 500 composite have risen 7.7% and 12.3%, respectively, in the same time frame. With a market capitalization of $28.61 billion, the average volume of shares traded in the last three months was 1.17 million.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/28/74114.jpg?v=1394791376" />
Image Source: Zacks Investment Research
The rally was largely driven by higher core commissions and fees, new business, solid retention, rate increases, strategic acquisitions, a strong financial position and effective capital deployment.
This Zacks Rank #2 (Buy) insurance broker surpassed earnings estimates in each of the last four quarters, the average being 9.82%.
The Zacks Consensus Estimate for 2024 and 2025 earnings has moved 1.6% and 1.8% north, respectively, in the past 30 days, reflecting analysts&#39; optimism on the stock.
<h3>Will the Bull Run Continue?</h3>
The Zacks Consensus Estimate for Brown &amp; Brown&#39;s 2024 earnings per share indicates an increase of 30.6% from the year-ago reported number. The consensus estimate for revenues is pegged at $4.68 billion, implying a year-over-year improvement of 10%.
The consensus estimate for 2025 earnings per share and revenues indicates an increase of 8.2% and 7.5%, respectively, from the corresponding 2024 estimates.
The expected long-term earnings growth is 11%. Earnings have increased 18.4% in the past five years, better than the industry average of 13.8%.
Commissions and fees, the main component of the top line, benefit from increasing new business, strong retention and continued rate increases for most lines of coverage. The top line witnessed a five-year annual growth rate of 14%. The company met its intermediate annual revenue goal of $4 billion, doubling in the last five years.
The insurance broker continually makes investments in boosting organic growth and margin expansion. It boasts an industry-leading adjusted EBITDAC margin.
Brown &amp; Brown&#39;s strategic buyouts help it capitalize on growing market opportunities, strengthen its compelling products and service portfolio, expand global reach and accelerate its growth rate. For the second quarter of 2024, the insurance broker completed 10 acquisitions with estimated annual revenues of $13 million and continued to build relationships with many other companies.
Banking on operational expertise, BRO boasts a strong liquidity position with an improving leverage ratio. The strength of its operating model and diversity of businesses ensures strong cash conversion. The company effectively deploys cash into acquisitions, capital expenditure and wealth distribution for shareholders via dividend increases.
BRO has an impressive dividend history, raising dividends for 30 straight years. Its five-year annualized dividend growth is 10.6%, and its dividend yield is 0.5%.
<h3>Other Stocks to Consider</h3>
Some other top-ranked stocks from the insurance industry are Arthur J. Gallagher &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ajg#NYSE">AJG</a>), Willis Towers Watson Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtw#NASDAQ">WTW</a>) and Ryan Specialty Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ryan#NYSE">RYAN</a>), each carrying a Zacks Rank #2 at present.
Arthur J. Gallagher&#39;s earnings surpassed estimates in each of the last four quarters, the average surprise being 1.93%. Shares of AJG have jumped 25.2% YTD. The Zacks Consensus Estimate for AJG&#39;s 2024 and 2025 earnings implies year-over-year growth of 15.8% and 12%, respectively.
Willis Towers Watson&#39;s earnings surpassed estimates in each of the last four quarters, the average surprise being 7.06%. Shares of WTW have jumped 14.3% YTD. The Zacks Consensus Estimate for WTW&#39;s 2024 and 2025 earnings implies year-over-year growth of 14.6% and 11.9%, respectively.
Ryan Specialty&#39;s earnings surpassed estimates in one of the last four quarters and matched in the other three, the average surprise being 0.4%. Shares of RYAN have jumped 52.1% YTD. The Zacks Consensus Estimate for RYAN&#39;s 2024 and 2025 earnings implies year-over-year growth of 31.1% and 21.9%, respectively.
<a href="https://www.zacks.com/stock/news/2321356/brown-brown-bro-gains-40-ytd-will-the-rally-last?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2321356">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Dividends

RYAN

Brown & Brown Gains 40% YTD: Will the Rally Last?

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Outperform and raises the price target from $320 to $323.

Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $323

KBW analyst Meyer Shields maintained a Buy rating on Willis Towers Watson (WTW – Research Report) today and set a price target of $359.00. The comp...

Willis Towers Watson (WTW) Receives a Rating Update from a Top Analyst

Tracking David Abrams' Abrams Capital Management Portfolio - Q3 2024 Update

Evercore ISI analyst David Motemaden maintained a Hold rating on Willis Towers Watson (WTW – Research Report) today and set a price target of $336....

Willis Towers Watson (WTW) Gets a Hold from Evercore ISI

In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Willis Towers Watson (WTW – Research Report), with a price ta...

Willis Towers Watson (WTW) Gets a Buy from TD Cowen

Tracking Seth Klarman's Baupost Group Holdings - Q3 2024 Update

BlackRock Sustainable U.S. Value Equity Fund Q3 2024 Commentary

Barclays analyst Alex Scott maintained a Sell rating on Willis Towers Watson (WTW – Research Report) today and set a price target of $302.00. The c...

Barclays Sticks to Their Sell Rating for Willis Towers Watson (WTW)

Barclays raised the firm's price target on WTW (WTW) to $302 from $278 and keeps an Underweight rating on the shares. The firm updated organic grow...

WTW price target raised to $302 from $278 at Barclays

WTW (WTW) announced that its Board of Directors approved an increase to the existing share repurchase authority in the amount of $1 billion. The $1...

WTW increases share repurchase program by $1B

WTW hikes share buyback program by $1B

CLVT

CMCSA

CPNG

CPRI

CTLP

CTLPP

FTRE

GDHLF

GOOG

GOOGL

JAZZ

LBTYA

LBTYB

LBTYK

LOAR

NUVB

SNRE

SNYNF

SOLV

TBPH

UHAL

VRSN

VSAT

Press Releases

World's largest investment managers see assets hit $128 trillion in return to growth

General

Pay still drives employee attraction and retention, but current pay programs fall short

WTW announces Kingdom of Saudi Arabia (K.S.A.) expansion with appointment of new Head of Insurance Broking

WTW announces new Cyber leader for Private Equity and Transactional Solutions

WTW expands Japan's Corporate Risk & Broking business with new insurance brokerage service

WTW Reports Third Quarter 2024 Earnings

US employers prioritize wellbeing but miss the mark with employees

WTW announces Growth Leader for Private Equity and Transactional Solutions (PE&TS)

WTW & Kayna Partner with Vibrant to support third-party vendor Cybersecurity Insurance Compliance

WTW Increases Share Repurchase Program by $1 Billion

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Willis Towers Watson

Vendite allo scoperto

Willis Towers Watson (NASDAQ:WTW) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO